PFA takes center stage at Heart Rhythm 2025 as medtech companies share new data

Heart Rhythm 2025 Heart Rhythm Society President Kenneth A. Ellenbogen, MD

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, speaks to attendees during Heart Rhythm 2025. Image courtesy of HRS.

Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies. 

Integrating Barostim into a Comprehensive Heart Failure Program: How Duke Is Improving Outcomes & Navigating Reimbursement Challenges

Duke University Health System has integrated Barostim into its comprehensive heart failure program. For patients with heart failure with reduced ejection fraction (HFrEF), Barostim is a device therapy that works with drug therapies to target the neurohormonal pathways responsible for heart failure progression and symptoms. Listen in as an advanced heart failure specialist discusses patient selection and post-implant management, the implant procedure, patient care pathways, and how Duke has incorporated Barostim into their system.

Mangione enters plea of 'not guilty' as federal trial moves forward

Luigi Mangione Mugshot Pennsylvania

Mugshot of Luigi Mangione taken by the Pennsylvania Department of Corrections. 

Source

Pennsylvania Department of Corrections

Luigi Mangione has officially entered a plea in the indictment against him for the murder of UnitedHealthcare CEO Brian Thompson. The federal case is now expected to move forward before the overlapping state murder trial, as the Department of Justice is seeking the death penalty.